Peoples Financial Services (NASDAQ:PFIS) Posts Quarterly Earnings Results, Beats Expectations By $0.56 EPS
Peoples Financial Services (NASDAQ:PFIS – Get Free Report) issued its earnings results on Tuesday. The financial services provider reported $1.64 EPS for the quarter, beating analysts’ consensus estimates of $1.08 by $0.56, Zacks reports. The business had revenue of $74.01 million during the quarter. Peoples Financial Services had a return on equity of 5.93% and […]
Peoples Financial Services (NASDAQ:PFIS) Posts Earnings Results, Beats Estimates By $0.56 EPS
Peoples Financial Services (NASDAQ:PFIS – Get Free Report) issued its earnings results on Tuesday. The financial services provider reported $1.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.56, Zacks reports. The company had revenue of $74.01 million for the quarter. Peoples Financial Services had a return on equity […]
Global Business Travel Group (NYSE:GBTG) Posts Earnings Results, Misses Estimates By $0.14 EPS
Global Business Travel Group (NYSE:GBTG – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.22) earnings per share for the quarter, missing the consensus estimate of ($0.08) by ($0.14), Zacks reports. Global Business Travel Group had a negative net margin of 1.66% and a negative return on equity of 1.26%. […]
American Financial Group (NYSE:AFG) Posts Earnings Results, Misses Estimates By $0.20 EPS
American Financial Group (NYSE:AFG – Get Free Report) posted its quarterly earnings data on Tuesday. The insurance provider reported $2.31 earnings per share for the quarter, missing analysts’ consensus estimates of $2.51 by ($0.20), Briefing.com reports. American Financial Group had a return on equity of 21.16% and a net margin of 11.06%. The firm had […]
Ultragenyx Pharmaceutical (NASDAQ:RARE) Posts Earnings Results, Beats Estimates By $0.05 EPS
Ultragenyx Pharmaceutical (NASDAQ:RARE – Get Free Report) issued its earnings results on Tuesday. The biopharmaceutical company reported ($1.40) earnings per share for the quarter, topping the consensus estimate of ($1.45) by $0.05, Briefing.com reports. Ultragenyx Pharmaceutical had a negative return on equity of 266.02% and a negative net margin of 121.57%. The business had revenue […]
last updated on 6 Nov 20:34